RTOG appoints new regulatory compliance director
The Radiation Therapy Oncology Group (RTOG) has named Nancy Soto as director of the protocol development and regulatory compliance department.
The group said that Soto will direct its protocol development, patient registration, on-site auditing and regulatory compliance activities.� RTOG is a National Cancer Institute (NCI)-funded national clinical trials group administered by the American College of Radiology (ACR).
Prior to coming to RTOG, Soto spent 17 years with Memorial Sloan Kettering Cancer Center in New York City, working in grants management and clinical trial research coordination. Most recently, Soto was a clinical project manager for investigator-initiated studies at Schering-Plough in its oncology phase IV global clinical trials management section.
Soto replaces Wilma Hoffman who was promoted to the position of RTOG senior director last year.
The group said that Soto will direct its protocol development, patient registration, on-site auditing and regulatory compliance activities.� RTOG is a National Cancer Institute (NCI)-funded national clinical trials group administered by the American College of Radiology (ACR).
Prior to coming to RTOG, Soto spent 17 years with Memorial Sloan Kettering Cancer Center in New York City, working in grants management and clinical trial research coordination. Most recently, Soto was a clinical project manager for investigator-initiated studies at Schering-Plough in its oncology phase IV global clinical trials management section.
Soto replaces Wilma Hoffman who was promoted to the position of RTOG senior director last year.